Clinical Trial Update: A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating safety and efficacy of adding metformin to FOLFOX6 or FOLFIRI as second-line therapy in previously treated advanced colorectal cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• metformin (metformin)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Previously Treated Advanced Colorectal Cancer | Phase 2 | Status: TERMINATED